492 related articles for article (PubMed ID: 22138051)
21. Changes in male reproductive health and effects of endocrine disruptors in Scandinavian countries.
Toppari J; Haavisto AM; Alanen M
Cad Saude Publica; 2002; 18(2):413-20. PubMed ID: 11923882
[TBL] [Abstract][Full Text] [Related]
22. Do environmental factors play a role in the aetiology of carcinoma in situ testis and the testicular dysgenesis syndrome?
Sonne SB; Hoei-Hansen CE; Fisher JS; Leffers H; Rajpert-de Meyts E; Skakkebaek NE
Verh Dtsch Ges Pathol; 2004; 88():144-51. PubMed ID: 16892545
[TBL] [Abstract][Full Text] [Related]
23. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome.
Boisen KA; Main KM; Rajpert-De Meyts E; Skakkebaek NE
Ann N Y Acad Sci; 2001 Dec; 948():90-9. PubMed ID: 11795400
[TBL] [Abstract][Full Text] [Related]
24. Temporal decline of sperm concentration: role of endocrine disruptors.
Cannarella R; Gül M; Rambhatla A; Agarwal A
Endocrine; 2023 Jan; 79(1):1-16. PubMed ID: 36194343
[TBL] [Abstract][Full Text] [Related]
25. International geographic correlation study of the prevalence of disorders of male reproductive health.
Serrano T; Chevrier C; Multigner L; Cordier S; Jégou B
Hum Reprod; 2013 Jul; 28(7):1974-86. PubMed ID: 23670171
[TBL] [Abstract][Full Text] [Related]
26. Is human fecundity declining?
Skakkebaek NE; Jørgensen N; Main KM; Rajpert-De Meyts E; Leffers H; Andersson AM; Juul A; Carlsen E; Mortensen GK; Jensen TK; Toppari J
Int J Androl; 2006 Feb; 29(1):2-11. PubMed ID: 16466518
[TBL] [Abstract][Full Text] [Related]
27. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
[TBL] [Abstract][Full Text] [Related]
28. Testicular dysgenesis syndrome.
Skakkebaek NE
Horm Res; 2003; 60 Suppl 3():49. PubMed ID: 14671395
[TBL] [Abstract][Full Text] [Related]
29. [Effects of endocrine disrupting chemicals on male reproductive function--epidemiological views].
Nozawa S; Iwamoto T
Nihon Eiseigaku Zasshi; 2006 Jan; 61(1):32-7. PubMed ID: 16506652
[TBL] [Abstract][Full Text] [Related]
30. Reduced seminal parameters associated with environmental DDT exposure and p,p'-DDE concentrations in men in Chiapas, Mexico: a cross-sectional study.
De Jager C; Farias P; Barraza-Villarreal A; Avila MH; Ayotte P; Dewailly E; Dombrowski C; Rousseau F; Sanchez VD; Bailey JL
J Androl; 2006; 27(1):16-27. PubMed ID: 16400073
[TBL] [Abstract][Full Text] [Related]
31. Temporal trends in bull semen quality: a comparative model for human health?
Wahl RL; Reif JS
Environ Res; 2009 Apr; 109(3):273-80. PubMed ID: 19181314
[TBL] [Abstract][Full Text] [Related]
32. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems.
Wohlfahrt-Veje C; Main KM; Skakkebaek NE
Clin Endocrinol (Oxf); 2009 Oct; 71(4):459-65. PubMed ID: 19222487
[TBL] [Abstract][Full Text] [Related]
33. Clinical correlates of environmental endocrine disruptors.
Safe S
Trends Endocrinol Metab; 2005; 16(4):139-44. PubMed ID: 15860409
[TBL] [Abstract][Full Text] [Related]
34. EDCs and male urogenital cancers.
Bornman MS; Aneck-Hahn NH
Adv Pharmacol; 2021; 92():521-553. PubMed ID: 34452696
[TBL] [Abstract][Full Text] [Related]
35. Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations.
Skakkebaek NE; Rajpert-De Meyts E; Jørgensen N; Main KM; Leffers H; Andersson AM; Juul A; Jensen TK; Toppari J
Int J Androl; 2007 Aug; 30(4):198-204; discussion 204-5. PubMed ID: 17705804
[TBL] [Abstract][Full Text] [Related]
36. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome.
Fisher JS
Reproduction; 2004 Mar; 127(3):305-15. PubMed ID: 15016950
[TBL] [Abstract][Full Text] [Related]
37. Per- and polyfluoroalkyl substances and male reproductive health: a systematic review of the epidemiological evidence.
Petersen KU; Larsen JR; Deen L; Flachs EM; Hærvig KK; Hull SD; Bonde JPE; Tøttenborg SS
J Toxicol Environ Health B Crit Rev; 2020 Aug; 23(6):276-291. PubMed ID: 32741292
[TBL] [Abstract][Full Text] [Related]
38. The Male Reproductive System and Endocrine Disruptors.
Schiesaro MG; Amato AML; Maneschi C; Sciabica V; Pigatto E; Sanna M
Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):686-703. PubMed ID: 34607552
[TBL] [Abstract][Full Text] [Related]
39. Country-specific chemical signatures of persistent environmental compounds in breast milk.
Krysiak-Baltyn K; Toppari J; Skakkebaek NE; Jensen TS; Virtanen HE; Schramm KW; Shen H; Vartiainen T; Kiviranta H; Taboureau O; Brunak S; Main KM
Int J Androl; 2010 Apr; 33(2):270-8. PubMed ID: 19780864
[TBL] [Abstract][Full Text] [Related]
40. Endocrine disruptors and estrogenic effects on male reproductive axis.
Sikka SC; Wang R
Asian J Androl; 2008 Jan; 10(1):134-45. PubMed ID: 18087652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
